Intern Med J:电子病历中青霉素ADR记录:过敏和不耐受傻傻分不清

2017-11-28 顾歆纯 环球医学

大部分在青霉素过敏标签范围内的患者可以耐受青霉素。不恰当的避免青霉素与住院、感染和治疗成本增加相关。2017年11月,发表在《Intern Med J》的一项研究调查了电子病历中青霉素的药物不良反应(ADR)记录。

大部分在青霉素过敏标签范围内的患者可以耐受青霉素。不恰当的避免青霉素与住院、感染和治疗成本增加相关。2017年11月,发表在《Intern Med J》的一项研究调查了电子病历中青霉素的药物不良反应(ADR)记录。

目的:在一项基于医院的大型电子病历中,考察了青霉素ADR记录。

方法:在南澳大利亚企业患者管理系统中,提取96708例患者的青霉素ADR记录。使用专家标准,确定ADR进入的一致性,以及进一步评价的适度性。

结果:在43001个唯一的ADR报告中,5023个青霉素ADR登记为过敏(n?=?4773,95.0%),而非不耐受(n?=?250,5.0%)。显着较大比例的ADR记录不包括反应描述(n?=?1052,20.9%)。使用预设的标准,10.1%的登记为过敏的报告与不耐受有一致的反应描述,31.0%的不耐受登记与过敏有一致的描述。事实上,所有ADR(n?=?4979,99.1%)都适合进一步评价病史或进行免疫检测,半数ADR(50.7%,n?=?2549)有记录反应,表明青霉素过敏的风险较低。

结论:该数据库中的青霉素过敏频率与医院人群中已知的青霉素过敏过度诊断具有一致性。ADR记录较差,记录不完整,分类具有不一致性。ADR分类过敏和不耐受的概念,或在全科医生登记ADR时无用。需要系统评价报告的ADR,以改善未来处方的信息质量。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1947212, encodeId=9d55194e21220, content=<a href='/topic/show?id=78af204639e' target=_blank style='color:#2F92EE;'>#不耐受#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20463, encryptionId=78af204639e, topicName=不耐受)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun May 20 19:53:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779375, encodeId=36aa1e79375e9, content=<a href='/topic/show?id=481620131e' target=_blank style='color:#2F92EE;'>#ADR记录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2013, encryptionId=481620131e, topicName=ADR记录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Sep 27 03:53:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459290, encodeId=b4581459290e1, content=<a href='/topic/show?id=2cc899065bc' target=_blank style='color:#2F92EE;'>#青霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99065, encryptionId=2cc899065bc, topicName=青霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd1b6130189, createdName=sunyl09, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608291, encodeId=41aa16082914e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265094, encodeId=fc7f2650946e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Nov 28 18:53:04 CST 2017, time=2017-11-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1947212, encodeId=9d55194e21220, content=<a href='/topic/show?id=78af204639e' target=_blank style='color:#2F92EE;'>#不耐受#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20463, encryptionId=78af204639e, topicName=不耐受)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun May 20 19:53:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779375, encodeId=36aa1e79375e9, content=<a href='/topic/show?id=481620131e' target=_blank style='color:#2F92EE;'>#ADR记录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2013, encryptionId=481620131e, topicName=ADR记录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Sep 27 03:53:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459290, encodeId=b4581459290e1, content=<a href='/topic/show?id=2cc899065bc' target=_blank style='color:#2F92EE;'>#青霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99065, encryptionId=2cc899065bc, topicName=青霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd1b6130189, createdName=sunyl09, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608291, encodeId=41aa16082914e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265094, encodeId=fc7f2650946e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Nov 28 18:53:04 CST 2017, time=2017-11-28, status=1, ipAttribution=)]
    2018-09-27 3631173
  3. [GetPortalCommentsPageByObjectIdResponse(id=1947212, encodeId=9d55194e21220, content=<a href='/topic/show?id=78af204639e' target=_blank style='color:#2F92EE;'>#不耐受#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20463, encryptionId=78af204639e, topicName=不耐受)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun May 20 19:53:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779375, encodeId=36aa1e79375e9, content=<a href='/topic/show?id=481620131e' target=_blank style='color:#2F92EE;'>#ADR记录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2013, encryptionId=481620131e, topicName=ADR记录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Sep 27 03:53:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459290, encodeId=b4581459290e1, content=<a href='/topic/show?id=2cc899065bc' target=_blank style='color:#2F92EE;'>#青霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99065, encryptionId=2cc899065bc, topicName=青霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd1b6130189, createdName=sunyl09, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608291, encodeId=41aa16082914e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265094, encodeId=fc7f2650946e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Nov 28 18:53:04 CST 2017, time=2017-11-28, status=1, ipAttribution=)]
    2017-11-30 sunyl09
  4. [GetPortalCommentsPageByObjectIdResponse(id=1947212, encodeId=9d55194e21220, content=<a href='/topic/show?id=78af204639e' target=_blank style='color:#2F92EE;'>#不耐受#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20463, encryptionId=78af204639e, topicName=不耐受)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun May 20 19:53:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779375, encodeId=36aa1e79375e9, content=<a href='/topic/show?id=481620131e' target=_blank style='color:#2F92EE;'>#ADR记录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2013, encryptionId=481620131e, topicName=ADR记录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Sep 27 03:53:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459290, encodeId=b4581459290e1, content=<a href='/topic/show?id=2cc899065bc' target=_blank style='color:#2F92EE;'>#青霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99065, encryptionId=2cc899065bc, topicName=青霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd1b6130189, createdName=sunyl09, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608291, encodeId=41aa16082914e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265094, encodeId=fc7f2650946e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Nov 28 18:53:04 CST 2017, time=2017-11-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1947212, encodeId=9d55194e21220, content=<a href='/topic/show?id=78af204639e' target=_blank style='color:#2F92EE;'>#不耐受#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20463, encryptionId=78af204639e, topicName=不耐受)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun May 20 19:53:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779375, encodeId=36aa1e79375e9, content=<a href='/topic/show?id=481620131e' target=_blank style='color:#2F92EE;'>#ADR记录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2013, encryptionId=481620131e, topicName=ADR记录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Sep 27 03:53:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459290, encodeId=b4581459290e1, content=<a href='/topic/show?id=2cc899065bc' target=_blank style='color:#2F92EE;'>#青霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99065, encryptionId=2cc899065bc, topicName=青霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd1b6130189, createdName=sunyl09, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608291, encodeId=41aa16082914e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Nov 30 08:53:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265094, encodeId=fc7f2650946e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Nov 28 18:53:04 CST 2017, time=2017-11-28, status=1, ipAttribution=)]
    2017-11-28 131****1460

    学习了受益匪浅

    0

相关资讯

河南省人民医院荣获电子病历应用五级医院称号

近日,河南省人民医院荣获“电子病历系统功能应用分级评价五级医院”称号,2016年度河南仅此一家。

电子病历被毁,手补居然错?

最近,一个在医院工作的网友跟我咨询这样一个问题:“上月的一场雷把医院的电脑损坏。因为资料没有备份,导致电脑里的2014年01月01日至2017年07月07日的入院病历、病程记录、医嘱丢失,通过技术未能复原。为此医院领导要求医生根据护理记录及医嘱补3年半的电子病程记录,部分医生认为违反原则,拒绝执行。请问这种电子病历能补吗?这样的病历丢失算谁的责任?”

语音助手兴起 电子病历的硬伤终于有了解决方案

2016年,亚马逊推出了一款智能控制设备Echo,同时还包含了一位名叫Alexa的语音助理。和Siri相似,Alexa可以接收相应语音命令。在使用Echo的时候,只需要说一声“Alexa”,就可以开始询问问题,包括新闻、创建任务提醒、设定闹钟时间或播放音乐等。同时,Alexa还可以和各种智能家居设备进行交互,用来控制恒温器或者调解灯光。看起来很酷是不是,更酷的是,Alexa又跟随名师梅奥医学中心(

美电子病历供应商巨头:电子病历EHR该换个名字了

电子病历的英文缩写是EHR(Electronic Health Record),以后,这个缩写可能要变了。美国最大的电子病历供应商之一Epic的CEO朱迪·福克纳想把EHR中的“E”换成“C”,让EHR变成CHR(Comprehensive Health Record,综合病历)。近日,在与Epic客户的一次会议中,福克纳说:“现在所有的东西都是电子的,‘E’也可以舍去了。我们现在要做的是,打破医

七成医务人员拥有他人密码,电子病历安全性引争议

电子健康病例(EHR)是在信息技术的支持下,保存、管理、传输和重现的数字化的患者医疗记录。多个国家正在逐步利用EHR替代医院的纸质就医记录。虽然EHR具有准确、高效和多功能性等特点,但一些潜在问题仍然不可避免。隐私安全可能是威胁电子病历信息安全的首要因素,含有个人隐私的大量数据泄露事件层出不穷。一周前,亚马逊就被曝出约有47GB的医疗数据遭到泄露,至少15万患者的血液测试结果、病历管理记录等意外暴

医疗事故索赔增加 电子病历的问题出在哪

为了提高医疗效率,避免重复的医疗检测和诊治流程,自2004年起,推广应用电子病历一直是美国政府推行医疗信息化的重要内容之一。如今,十多年过去了,电子病历也改善医疗服务质量的同时,也带来了不可忽视的弊端。